Birkenstock 1774 is continuing to reimagine the classics with the Arizona CosNy in Nylon, giving the iconic Arizona sandals a ...

While competitors may try to mimic the classic style of Birkenstock shoes, all diehard Birkenstock fans know this to be true: ...

If your Birkenstock sandals are made from smooth leather, simply wiping them over with a soft dry cloth should do the trick. If they’re suede, you’ll need to use a suede brush, and if they’re nubuck, ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

There's nothing like a bit of patent discussion to get us Nintendo fans all excited, eh? While the latest legal bagsy from the Big N isn't quite as juicy as the potential hardware features we've ...

“For its part, Moderna has asserted certain of its patents against its direct competitors Pfizer+BioNTech in the United States and abroad, scoring a recent victory in Germany with a finding of ...

It’s time to ditch the Hawaiian printed tops and cargo shorts—the men’s collections this season are here to welcome you to the ultimate trends to embody with stride.

The patent dispute dates back to December 2022, when Samsung Display filed complaints against 17 component wholesalers in the United States. In the complaints, Samsung Display argued that OLEDs it ...

Prods. R&D, Inc. v. Amneal Pharms. of N.Y., LLC is poised to significantly reshape the landscape of Orange Book patent listings and Hatch-Waxman litigation, according to a new analysis by Gregory J.

Photo by John Milner via Getty Images. Babuk ransomware, a cybercrime ring that targets major enterprises, has posted unverified claims about a massive data breach at Orange, a major telecom.

Right now at Rue La La, a site that offers notable deals on designer clothes, shoes, accessories, and more, you can snag select comfy Birkenstock sandals for up to 39 percent off, bringing their ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that have taken the leap off the patent cliff. Big Pharma is staring down the ...